0
Xilio Therapeutics, Inc. Banner Image

Xilio Therapeutics, Inc.

  • Ticker XLO
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Xilio Therapeutics, Inc. Logo Image
  • 51-200 Employees
  • Based in Waltham, Massachusetts
Xilio Therapeutics is a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology (I-O) therapies with the goal of significantly improving outcomes for people living with cancer without the systemic side effects of current I-O treatments. The company is using its proprietary geographically precise solutions (GPS) platform to build a pipeline of novelMore, tumor-activated molecules, including antibodies, cytokines and other biologics, which are designed to optimize their therapeutic index and localize anti-tumor activity within the tumor microenvironment. Xilio is currently advancing multiple programs for tumor-activated I-O treatments in clinical development, as well as programs in preclinical development.
Xilio Therapeutics, Inc.

Most Recent Annual Report

Xilio Therapeutics, Inc.
MOST RECENT 2022 Annual Report and Form 10K

Older/Archived Annual Reports

Xilio Therapeutics, Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!